Page 34 - Central Drug Authority Annual Report 2021

Programme
2) World Drug Report (WDR) 2.5 AFRICAN UNION (AU)
7KH :'5 LV DQ DQQXDO SXEOLFDWLRQ WKDW SUHVHQWV D 6RXWK $IULFD LV D PHPEHU RI WKH $8 DQG WKURXJK LWV 0LQLVWHU
FRPSUHKHQVLYH DVVHVVPHQW RI WKH LQWHUQDWLRQDO GUXJ RI 6RFLDO 'HYHORSPHQW SDUWLFLSDWHG LQ WKH GHYHORSPHQW RI
problem, with detailed information on the illicit drug WKH ȝ $8 3ODQ RI $FWLRQ $83$ ZKLFK IRFXVHG RQ
VLWXDWLRQ ,W SURYLGHV HVWLPDWHV DQG LQIRUPDWLRQ RQ SDWWHUQV GUXJ FRQWURO DW WKH $8 &RQIHUHQFH RI 0LQLVWHUV IRU 'UXJ
DQG WUHQGV LQ WKH SURGXFWLRQ WUDIˉFNLQJ DQG XVH RI NH\ &RQWURO 7KH 'HSDUWPHQW RI 6RFLDO $IIDLUV RI WKH $IULFDQ
GUXJV 7KH UHSRUW EDVHG RQ GDWD DQG HVWLPDWHV FROOHFWHG RU 8QLRQ &RPPLWWHH $8& LV WKH FHQWUDO GUXJ SROLF\
SUHSDUHG E\ *RYHUQPHQWV 812'& DQG RWKHU LQWHUQDWLRQDO GHYHORSLQJ ERG\ RI WKH $8 ,WV IXQFWLRQV LQFOXGH WKH
institutions, attempts to identify patterns and trends in the establishment of and consultation with a continental team
HYROXWLRQ RI JOREDO LOOLFLW PDUNHWV RI H[SHUWV RQ YDULRXV GUXJ UHODWHG LVVXHV ,W IXUWKHU DLPV WR
maintain a continental database of drug-related matters and
WR SUHSDUH UHOHYDQW UHSRUWV
7KH &'$ FRQWULEXWHV GDWD IRU LQFOXVLRQ LQ WKH :'5 DQG LV
HQJDJHG LQ D SURMHFW ZLWK WKH 3UHWRULD RIˉFH RI 812'& WR Aims and Objectives of the AUPA
LGHQWLI\ WKH QDWXUH DQG H[WHQW RI LQMHFWLRQ GUXJ XVH ,'8 7KH VWUDWHJLF REMHFWLYH RI WKH $83$ LV WR LPSURYH WKH KHDOWK
DQG ,'8 +,9 $,'6 OLQNV DV ZHOO DV ZD\V WR FRXQWHU WKH ODWWHU security and socioeconomic wellbeing of people in Africa by
OLQNV DSSURSULDWHO\ UHGXFLQJ GUXJ XVH LOOLFLW WUDIˉFNLQJ DQG DVVRFLDWHG FULPHV
7KH $8& PRQLWRUV WKH LPSOHPHQWDWLRQ RI UHVROXWLRQV DW D
2.3 INTERNATIONAL NARCOTIC CONTROL BOARD (INCB) PHPEHU VWDWH OHYHO
(VWDEOLVKHG LQ WKH ,1&% VHH KWWSV ZZZ LQFE RUJ LV 2.6 BRAZIL, RUSSIA, INDIA, CHINA, AND SOUTH AFRICA
an independent and quasi-judicial monitoring body for the (BRICS) FORMAL ANTIDRUG COMMITTEE
LPSOHPHQWDWLRQ RI WKH 8QLWHG 1DWLRQV LQWHUQDWLRQDO GUXJ
FRQWURO FRQYHQWLRQV DQG 6RXWK $IULFDQ LV LWV FXUUHQW 7KH &'$ LV UHSUHVHQWHG RQ WKH %5,&6 )RUPDO $QWL 'UXJ
3UHVLGHQW 2QH RI LWV NH\ IXQFWLRQV LV WR LGHQWLI\ DQG FRUUHFW &RPPLWWHH XQGHU 6RXWK $IULFDȠV PHPEHUVKLS RI WKLV
weaknesses in (inter)national systems for controlling the HFRQRPLF VWUXFWXUH 7KH SXUSRVH RI WKLV FRPPLWWHH LV WR
LOOLFLW PDQXIDFWXUH RI WUDIˉFNLQJ LQ DQG XVH RI GUXJV DSDUW LQYHVWLJDWH WKH FRUUHODWLRQ EHWZHHQ VXEVWDQFH DEXVH DQG
from assessing whether chemicals used in the manufacture WKH VRFLDO LOOV SUHVHQW LQ FRPPXQLWLHV ZLWKLQ PHPEHU VWDWHV
RI LOOLFLW GUXJV VKRXOG EH SODFHG XQGHU LQWHUQDWLRQDO FRQWURO 7KH LQWHUQDWLRQDO LOOLFLW GUXJ WUDGH KDV PXWDWHG LQWR D WKUHDW
:KHUH 8QLWHG 1DWLRQV LQWHUQDWLRQDO GUXJ FRQWURO WR LQWHUQDWLRQDO SHDFH GHYHORSPHQW DQG VHFXULW\ 7KH LOOLFLW
FRQYHQWLRQV WUHDWLHV DUH YLRODWHG WKH ,1&% GLVFXVVHV WKH trade is linked to transnational organised terrorism, human
YLRODWLRQV ZLWK WKH UHOHYDQW JRYHUQPHQWV SURSRVHV WUDIˉFNLQJ DQG WKH UXLQLQJ RI GHYHORSLQJ QDWLRQV 7KH LOOLFLW
appropriate remedial measures and, where necessary, assists GUXJ YDOXH FKDLQ SUHVHQWV D PDMRU WKUHDW WR DOO %5,&6
WKHVH JRYHUQPHQWV LQ RYHUFRPLQJ GLIˉFXOWLHV LQ WKLV UHVSHFW PHPEHU VWDWHV
0RUHRYHU ZKHUH UHPHGLDO PHDVXUHV KDYH QRW EHHQ WDNHQ
,1&% PD\ FDOO WKH PDWWHU WR WKH DWWHQWLRQ RI WKH &1' DQG 'XULQJ WKH )LIWK %5,&6 6XPPLW LQ 'XUEDQ LQ 0DUFK WKH
WKH (FRQRPLF DQG 6RFLDO &RXQFLO RI WKH 8QLWHG 1DWLRQV H7KHNZLQL $FWLRQ 3ODQ ZDV DJUHHG XSRQ 7KLV SODQ PDNHV
SURYLVLRQ IRU %5,&6 DQWL GUXJ FRRSHUDWLRQ DV D QHZ DJHQGD
2.4 WORLD HEALTH ORGANISATION (WHO) LVVXH 7KH SODQ VXSSRUWV WKH GHYHORSPHQW SURPRWLRQ DQG
LQWHQVLˉFDWLRQ RI PHDVXUHV WR IDFLOLWDWH LQWUD %5,&6 FRRSHU-
7KH &'$ OLDLVHV ZLWK WKH :+2 WKURXJK WKH ORFDO :+2 RIˉFH DWLRQ LQ WKH SUHYHQWLRQ DQG FRPEDWLQJ RI WKH GUXJ YDOXH
DV ZHOO DV WKURXJK JRYHUQPHQW UHSUHVHQWDWLYHV RQ WKH &'$ chain and associated crimes, in line with drug-related
ZKR FROODERUDWH ZLWK WKH :+2 VXFK DV WKH UHSUHVHQWDWLYH RI LQWHUQDWLRQDO SURWRFROV DQG REOLJDWLRQV
WKH 'HSDUWPHQW RI +HDOWK 7KH ODWWHU JRYHUQPHQW
GHSDUWPHQW DQG LWV SDUWQHUV ZLWKLQ FLYLO VRFLHW\ VXFK DV WKH
05& KDYH FORVH ZRUNLQJ UHODWLRQVKLSV ZLWK WKH :+2 H J
FRQFHUQLQJ WKH SURYLVLRQ RI UHOHYDQW GDWD RQ DOFRKRO DQG
WREDFFR XVH LQ 6RXWK $IULFD
32 Annual R epor t 2020/2021 C entral Drug Authority
Annual Report 2020/2021 Central Drug Authority
,6683 LPSOHPHQWV LWV DFWLYLWLHV LQ FRQVXOWDWLRQ ZLWK 2.9 INTERNATIONAL NETWORK ON HEPATITIS IN
&DQDGLDQ &HQWUH RQ 6XEVWDQFH $EXVH &&6$ SUBSTANCE USERS (INHSU)
&RORPER 3ODQ
&RRSHUDWLRQ 3URJUDPPH RQ 'UXJV 3ROLFLHV &232/$' ,1+68 LV DQ LQWHUQDWLRQDO RUJDQLVDWLRQ GHGLFDWHG WR
(XURSHDQ 0RQLWRULQJ &HQWUH IRU 'UXJV DQG 'UXJ VFLHQWLˉF NQRZOHGJH H[FKDQJH NQRZOHGJH WUDQVODWLRQ DQG
$GGLFWLRQ (0&''$ DGYRFDF\ IRFXVHG RQ KHSDWLWLV & SUHYHQWLRQ DQG FDUH IRU
(XURSHDQ 6RFLHW\ IRU 3UHYHQWLRQ 5HVHDUFK (8635 SHRSOH ZKR XVH GUXJV ,QFUHDVLQJ KHSDWLWLV & WHVWLQJ OLQNDJH
2UJDQLVDWLRQ RI $PHULFDQ 6WDWHV ,QWHU $PHULFDQ 'UXJ to care, treatment and cure among people who use drugs is
Abuse Control Commission ( RI SDUDPRXQW LPSRUWDQFH 7KLV LV DQ LQLWLDWLYH WKDW WKH &'$
VXSSRUWV
6RFLHW\ IRU 3UHYHQWLRQ 5HVHDUFK 635
7KH (XURSHDQ 3UHYHQWLRQ 6WDQGDUGV 3DUWQHUVKLS 7KH H[WHQW WR ZKLFK WKH &'$ ZDV DEOH WR H[SORUH DQG H[SORLW
8QLWHG 1DWLRQV 2IˉFH RQ 'UXJV DQG &ULPH 812'& WKHVH SDUWQHUVKLSV DQG UHODWLRQVKLSV KDV QRW EHHQ RSWLPDO
8 6 'HSDUWPHQW RI 6WDWHȠV %XUHDX RI ,QWHUQDWLRQDO ,QGLYLGXDO GHSDUWPHQWV ZHUH KRZHYHU DEOH WR IRUJH
1DUFRWLFV DQG /DZ (QIRUFHPHQW $IIDLUV ,1/ relationships and interact with these agencies in line with
:RUOG +HDOWK 2UJDQLVDWLRQ :+2 VHFWRU SROLFLHV DQG VHUYLFH GHOLYHU\ PDQGDWHV DV LQGLFDWHG LQ
WKH GHSDUWPHQWDO DQG VHFWRU UHSRUWV EHORZ
7KH PDQGDWHV RI WKH &1' ZHUH IXUWKHU H[SDQGHG LQ
7KH &1' LV RQH RI WKH IXQFWLRQDO FRPPLVVLRQV RI WKH
ZKHQ LW ZDV HPSRZHUHG WR DSSURYH WKH EXGJHW RI WKH
(FRQRPLF DQG 6RFLDO &RXQFLO (&262& RI WKH 8QLWHG
8QLWHG 1DWLRQV ,QWHUQDWLRQDO 'UXJ &RQWURO 3URJUDPPH
1DWLRQV DQG LV WKH FHQWUDO GUXJ SROLF\PDNLQJ ERG\ LQ WKH
ZKLFK LV DGPLQLVWHUHG E\ 812'& DQG WR ˉQDQFH PHDVXUHV WR
8QLWHG 1DWLRQV ,W KDV LPSRUWDQW IXQFWLRQV LQ IRUFH WRGD\
FRPEDW WKH ZRUOG GUXJ SUREOHP
under the drug control treaties and can amend the sched-
XOHV RI FRQWUROOHG VXEVWDQFHV XQGHU WKH 6LQJOH &RQYHQWLRQ
RQ 1DUFRWLF 'UXJV DQG WKH &RQYHQWLRQV RQ 3V\FKRWURSLF
5) Monitoring political commitments on drug control:
6XEVWDQFHV 7KH FHQWUDO GUXJ DXWKRULWLHV RU VLPLODU ERGLHV RI
7KH &1' ZDV DOVR PDQGDWHG WR PRQLWRU WKH RXWFRPH RI WKH
DOO WKH PHPEHU VWDWHV RI WKH &1' DWWHQG &1' VHVVLRQV WR
6SHFLDO 6HVVLRQ RI WKH *HQHUDO $VVHPEO\ RQ FRXQWHULQJ
report on and compare the situation in their countries and
the world drug problem, as well as the renewed commit-
the lessons learnt during the implementation of the respec-
PHQWV HQVKULQHG LQ WKH 3ROLWLFDO 'HFODUDWLRQ DQG 3ODQ
WLYH QDWLRQDO GUXJ PDVWHU SODQV
RI $FWLRQ
1) Mandate and functions of the CND:
6) Link between the CDA and the CND
7KH &1' UHYLHZV DQG DQDO\VHV WKH JOREDO GUXJ FRQWURO
6RXWK $IULFD EHFDPH D PHPEHU RI WKH &1' LQ &RQVH-
situation, considering the interrelated issues of drug abuse
TXHQWO\ 6RXWK $IULFD LV UHSUHVHQWHG RQ WKH &1' DQG SDUWLFL-
SUHYHQWLRQ UHKDELOLWDWLRQ RI GUXJ XVHUV DQG WKH VXSSO\ RI
SDWHV LQ &1' DQQXDO PHHWLQJV 7KH DQQXDO VHVVLRQ RI WKH
DQG WUDIˉFNLQJ LQ LOOLFLW GUXJV ,W DFWV WKURXJK UHVROXWLRQV DQG
&1' JLYHV PHPEHU FRXQWULHV WKH RSSRUWXQLW\ WR SDUWLFLSDWH
GHFLVLRQV
in the formulation of international drug policies that are
PDQGDWRU\ IRU PHPEHU FRXQWULHV 7KH &'$ SDUWLFLSDWHV LQ
2) Functional Commission of the Economic and Social
&1' DQQXDO PHHWLQJV JLYHQ WKDW LW LV D VWDWXWRU\ ERG\ ZLWKLQ
Council (ECOSOC)
'6' PDQGDWHG E\ WKH 3UHYHQWLRQ RI DQG 7UHDWPHQW IRU
6XEVWDQFH $EXVH $FW $FW RI WR FRPEDW VXEVWDQFH
7KH &1' ZDV HVWDEOLVKHG E\ WKH (FRQRPLF DQG 6RFLDO &RXQ-
XVH DQG DEXVH LQ 6RXWK $IULFD
FLO RI WKH 8QLWHG 1DWLRQV DV RQH RI LWV IXQFWLRQDO FRPPLV-
VLRQV RQ )HEUXDU\ 5HVROXWLRQ , 7KH &1' DVVLVWV
,W VKRXOG DOVR EH ERUQH LQ PLQG WKDW WKH &'$ LV UHTXLUHG
WR UHSRUW DQQXDOO\ WR '6' RQ 6RXWK $IULFDȠV FRQWULEXWLRQ
WKH FRXQFLO LQ VXSHUYLVLQJ WKH DSSOLFDWLRQ RI LQWHUQDWLRQDO
WRZDUGV WKH LPSOHPHQWDWLRQ RI WKH YDULRXV LQWHUQDWLRQDO
GUXJ FRQWURO WUHDWLHV ,W DOVR DGYLVHV WKH &RXQFLO RQ WKH
GUXJ FRQWURO WUHDWLHV DQG WKDW &'$ VWDNHKROGHUV LQFOXG-
control of narcotic drugs and psychotropic substances and
LQJ WKH QDWLRQDO GHSDUWPHQWV SURYLQFLDO GHSDUWPHQWV DQG
WKHLU SUHFXUVRUV
QRQ JRYHUQPHQW RUJDQLVDWLRQV LQ 6RXWK $IULFD PXVW EH
IRFXVHG RQ FRPEDWLQJ VXEVWDQFH XVH DQG DEXVH
3) Normative Functions:
7KH &1' KDV LPSRUWDQW QRUPDWLYH IXQFWLRQV LQ WHUPV RI
2.2 UN OFFICE ON DRUGS AND CRIME (UNODC)
LQWHUQDWLRQDO GUXJ FRQWURO FRQYHQWLRQV ,W LV DXWKRULVHG WR
FRQVLGHU WKH DLPV RI WKHVH FRQYHQWLRQV DQG HQVXUH WKHLU
LPSOHPHQWDWLRQ $V D WUHDW\ RUJDQ XQGHU WKH 6LQJOH &RQYHQ-
1) Aims and Functions
WLRQ RQ 1DUFRWLF 'UXJV RI DQG WKH &RQYHQWLRQ RQ
812'& ZDV HVWDEOLVKHG LQ DQG LWV KHDGTXDUWHUV DUH LQ
3V\FKRWURSLF 6XEVWDQFHV RI WKH &1' LV HPSRZHUHG
9LHQQD $XVWULD ,W KDV ˉHOG RIˉFHV DQG RQH LV ORFDWHG LQ
EDVHG RQ UHFRPPHQGDWLRQV E\ WKH :+2 WR SODFH QDUFRWLF
3UHWRULD 6RXWK $IULFD 7KH ORQJ WHUP DLPV RI 812'& DUH WR
drugs and psychotropic substances under international
HTXLS JRYHUQPHQWV WR KDQGOH LVVXHV UHODWHG WR GUXJV FULPH
FRQWURO 7KH &RQYHQWLRQ $JDLQVW ,OOLFLW 7UDIˉF LQ 1DUFRWLF
WHUURULVP DQG FRUUXSWLRQ $ERXW RI LWV IXQGLQJ FRPHV
'UXJV DQG 3V\FKRWURSLF 6XEVWDQFHV RI HPSRZHUV WKH
IURP YROXQWDU\ GRQDWLRQV PDLQO\ IURP JRYHUQPHQWV
&1' RQ WKH UHFRPPHQGDWLRQ RI WKH ,1&% WR SODFH SUHFXUVRU
chemicals frequently used for the manufacture of illicit
GUXJV XQGHU LQWHUQDWLRQDO FRQWURO 7KH &1' LV DOVR HPSRZ-
HUHG WR UHPRYH RU PRGLI\ LQWHUQDWLRQDO FRQWURO PHDVXUHV IRU
GUXJV SV\FKRWURSLF VXEVWDQFHV DQG SUHFXUVRUV
2.1 COMMISSION ON NARCOTIC DRUGS (CND) 4) Governing body of the UNODC International Drug Control
2.7 THE COLOMBO PLAN
7KH &RORPER 3ODQ LV RQH RI WKH ROGHVW LQWHUJRYHUQPHQWDO
LQLWLDWLYHV LQ WKH $VLDQ 3DFLˉF 5HJLRQ DQG ZDV RIˉFLDOO\ Programme for the Private Sector: 7KLV SURJUDPPH LV
ODXQFKHG E\ $XVWUDOLD &DQDGD ,QGLD 3DNLVWDQ 1HZ =HDODQG JHDUHG WRZDUGV SURYLGLQJ WKRVH GHSHQGHQW RQ GUXJV ZLWK D
6UL /DQND DQG WKH 8QLWHG .LQJGRP LQ ȟVHFRQG FKDQFHȠ WR OLYLQJ D OLIH RI TXDOLW\ 7KH SURJUDPPH LV
WKHUHIRUH FDOOHG WKH 6HFRQG &KDQFH 3URJUDPPH
1) Aims and Objectives of The Colombo Plan Programme for the Public Administration and Environment:
ȧ 7R SURPRWH LQWHUHVW LQ VXSSRUW RI HFRQRPLF DQG VRFLDO 7KH DFWLYLWLHV RI WKLV SURJUDPPH IRFXV RQ FOLPDWH FKDQJH
GHYHORSPHQW LQ PHPEHU VWDWHV DQG WKH HPSRZHUPHQW RI ZRPHQ /RQJ WHUP 6FKRODUVKLSV
ȧ 7R SURPRWH WHFKQLFDO FR RSHUDWLRQ DQG WKH VKDULQJ RI 3URJUDPPH 7KLV SURJUDPPH SURYLGHV VFKRODUVKLSV WR WKRVH
technology among member states, and LQ QHHG
• 7R UHYLHZ WKH UHOHYDQW LQIRUPDWLRQ ,W DOVR DLPV WR
IDFLOLWDWH WKH WUDQVIHU DQG VKDULQJ RI GHYHORSPHQW 2.8 ISSUP GLOBAL
experiences among member countries, especially
WKRVH LQ WKH VRXWKHUQ KHPLVSKHUH ,6683 *OREDO ZDV LQLWLDWHG LQ WKURXJK ,1/ ZRUNLQJ LQ
FRQVXOWDWLRQ ZLWK WKH $IULFDQ 8QLRQ 2$6 &,&$' &RORPER
2) Programmes of Colombo Plan 3ODQ 812'& DQG :+2 ,W ZDV HVWDEOLVKHG LQ WKH 8QLWHG
7KH IRXU SHUPDQHQW SURJUDPPHV FDUULHG RXW E\ WKH &RORP- .LQJGRP DV D QRW IRU SURˉW FRPSDQ\ OLPLWHG E\ JXDUDQWHH LQ
ER 3ODQ DUH )HEUXDU\ ,W LV D XQLTXH LQLWLDWLYH RIIHULQJ DQ LQWHUQD-
tional and credible professional membership that brings
WRJHWKHU ERWK WKH WUHDWPHQW DQG SUHYHQWLRQ ZRUNIRUFH
7KH 'UXJ $GYLVRU\ 3URJUDPPH '$3 concerned with substance abuse,
7KH 3URJUDPPH IRU 3XEOLF $GPLQLVWUDWLRQ DQG
(QYLURQPHQW DQG 7KH 3URJUDPPH IRU
3ULYDWH 6HFWRU 'HYHORSPHQW DQG WKH /RQJ WHUP 7KH ,6683 DLPV WR SURYLGH SURIHVVLRQDOV ZRUNLQJ LQ SXEOLF
6FKRODUVKLSV 3URJUDPPH WUHDWPHQW FHQWUHV DQG SUHYHQWLRQ ˉHOGV ZLWK WUDLQLQJ WR
HTXLS WKHP ZLWK VNLOOV DQG NQRZOHGJH WR FRPEDW 6XEVWDQFH
3) The Link between the CDA and the Colombo Plan 8VH 'LVRUGHUV ,W HQDEOHV WKHVH SURIHVVLRQDOV WR DSSO\
7KH &'$ KDV VXSSRUWHG WKH &RORPER 3ODQ LQLWLDWLYHV VFLHQFH PDNLQJ LW DFFHVVLEOH DQG FRPSUHKHQVLEOH IRU HYHU\-
SURJUDPPHV DQG WUDLQLQJ VHVVLRQV ZLWKLQ 6RXWK $IULFD 2QFH RQH ZLWKLQ WKH LQWHUQDWLRQDO GUXJ WUHDWPHQW DQG SUHYHQWLRQ
DFFUHGLWHG E\ WKH 6RXWK $IULFDQ 4XDOLˉFDWLRQV $XWKRULW\ FRPPXQLW\ ,W LV DOVR SURIHVVLRQDOLVLQJ WKH SUHYHQWLRQ DQG
6$4$ WKH YDULRXV SURJUDPPHV VKRXOG EH YDOXDEOH WRROV LQ treatment workforce, to promote quality standards, ethical,
WKH &'$ȠV HIIRUWV WR VWUHQJWKHQ LWV VXSSRUW VWUXFWXUHV 36$)V DQG HYLGHQFH EDVHG SUDFWLFH ,W LV DQ LQWHUQDWLRQDO RUJDQLVD-
DQG /'$&V tion that was set up to meet the needs and challenges faced
E\ WKH SUHYHQWLRQ DQG WUHDWPHQW ZRUNIRUFH
The key characteristics of these programmes are as follows:
Drug Advisory Programme (DAP): 7KLV SURJUDPPH DLPV WR )LQDOO\ SUHYHQWLRQ DQG WUHDWPHQW VFLHQFH KDV PRYHG
build capacity for drug demand reduction in the Asian and VXEVWDQWLDOO\ RYHU UHFHQW \HDUV 7KH IROORZLQJ DUH WKH UHFHQW
3DFLˉF 5HJLRQ ,W HQFRXUDJHV QDWLRQDO HIIRUWV DPRQJ FRXUVHV WKDW DUH DLPHG DW SURYLGLQJ SURIHVVLRQDOV ZLWK
continuing education and sharpening their skills and knowl-
PHPEHU FRXQWULHV WRZDUGV GHPDQG UHGXFWLRQ '$3 LQLWLD- HGJH LQ WKH ˉHOG
WLYHV LQFOXGH WKH HVWDEOLVKPHQW RI QDWLRQDO GUXJ IRFDO
points, the formulation of national drug policy, the imple- 8QLYHUVDO 3UHYHQWLRQ &XUULFXOXP
PHQWDWLRQ RI GUXJ GHPDQG UHGXFWLRQ LQLWLDWLYHV WKH LQLWLD- 8QLYHUVDO 7UHDWPHQW &XUULFXOXP
WLRQ RI WKH $IJKDQ GUXJ GHPDQG UHGXFWLRQ LQLWLDWLYH DQG WKH ,W LV LPSRUWDQW WR VWDWH WKDW WKH FRXUVHV DERYH ZHUH VXSSRUW-
$VLDQ &HQWUH IRU &HUWLˉFDWLRQ DQG (GXFDWLRQ RI $GGLFWLRQ HG E\ ,1/ DQG WKH &RORPER 3ODQ
3URIHVVLRQDOV $&&(
7KH (XURSHDQ 'UXJ 3UHYHQWLRQ 4XDOLW\ 6WDQGDUGV LV IXQGHG
The ACCE initiatives ZHUH HVWDEOLVKHG LQ DV WKH E\ WKH (XURSHDQ 8QLRQ DQG XQGHUWDNHQ E\ WKH (XURSHDQ
WUDLQLQJ DQG FUHGHQWLDOLQJ DUP RI WKH '$3 7KH $&&( LV DQ 3UHYHQWLRQ 6WDQGDUGV 3DUWQHUVKLS DQG WKH ,QWHUQDWLRQDO
LQWHJUDO SDUW RI WKH JOREDO LQLWLDWLYH IXQGHG E\ WKH %XUHDX 6WDQGDUGV RQ 'UXJ 8VH 3UHYHQWLRQ SURGXFHG E\ 812'&
IRU ,QWHUQDWLRQDO 1DUFRWLFV DQG /DZ (QIRUFHPHQW $IIDLUV RI
WKH 86 'HSDUWPHQW RI 6WDWH